Viewing StudyNCT00200512



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00200512
Status: COMPLETED
Last Update Posted: 2005-12-16
First Post: 2005-09-13

Brief Title: Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months
Sponsor: Mylan Bertek Pharmaceuticals
Organization: Mylan Bertek Pharmaceuticals

Organization Data

Organization: Mylan Bertek Pharmaceuticals
Class: INDUSTRY
Study ID: APO301
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Mylan Bertek Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators